Soleus Capital Management, L.P. Dice Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.86 - $46.71 $2.42 Million - $4.36 Million	-93,447 Reduced 53.88%	80,000 $3.72 Million
Q4 2022 Feb 14, 2023	SELL	$19.77 - $42.23 $7.15 Million - $15.3 Million	-361,911 Reduced 67.6%	173,447 $5.41 Million
Q3 2022 Nov 14, 2022	SELL	$14.97 - $22.65 $4.2 Million - $6.35 Million	-280,382 Reduced 34.37%	535,358 $10.9 Million
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $2.22 Million - $3.72 Million	-168,254 Reduced 17.1%	815,740 $12.7 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $2.52 Million - $4.33 Million	173,054 Added 21.34%	983,994 $18.8 Million
Q4 2021 Feb 14, 2022	SELL	$22.41 - $37.54 $1.55 Million - $2.59 Million	-68,963 Reduced 7.84%	810,940 $20.5 Million
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $28.1 Million - $32.6 Million	879,903 New	879,903 $28.8 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.